Get the Stockscreener App
3.07
4.36%
-0.14
Cumberland Pharmaceuticals Inc stock is traded at $3.07, with a volume of 64,312.
It is down -4.36% in the last 24 hours and down -1.60% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$3.21
Open:
$3.4
24h Volume:
64,312
Relative Volume:
1.53
Market Cap:
$45.33M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-4.2055
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
-12.03%
1M Performance:
-1.60%
6M Performance:
-36.44%
1Y Performance:
+174.11%
1-Day Range:
$3.00
$3.40
1-Week Range:
$3.00
$3.53
52-Week Range:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
2525 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.03 | 48.02M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
143.77 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.38 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.2444 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
442.98 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Heatmap analysis for Cumberland Pharmaceuticals Inc. and competitorsStop Loss & High Accuracy Trade Signal Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. a candidate for recovery playOil Prices & AI Driven Price Forecasts - newser.com
Is Cumberland Pharmaceuticals Inc. stock trading near support levels2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Applying chart zones and confluence areas to Cumberland Pharmaceuticals Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com
Regression analysis insights on Cumberland Pharmaceuticals Inc. performanceRecession Risk & Long-Term Capital Growth Strategies - newser.com
Cumberland Pharmaceuticals Inc. stock outlook for YEAREarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Visual analytics tools that track Cumberland Pharmaceuticals Inc. performanceQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
How to forecast Cumberland Pharmaceuticals Inc. trends using time seriesJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Has Cumberland Pharmaceuticals Inc. formed a bullish divergenceWall Street Watch & Weekly Top Stock Performers List - newser.com
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidance2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Can Cumberland Pharmaceuticals Inc. stock sustain institutional interestJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Cumberland Pharmaceuticals (Nasdaq: CPIX) to Report Q3 2025 Results, Hosting Investor Call - Stock Titan
Will Cumberland Pharmaceuticals Inc. stock maintain growth storyEarnings Trend Report & Accurate Intraday Trade Tips - Fundação Cultural do Pará
How moving averages guide Cumberland Pharmaceuticals Inc. tradingJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
What insider trading reveals about Cumberland Pharmaceuticals Inc. stockWeekly Investment Summary & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Published on: 2025-10-27 22:22:34 - newser.com
Cumberland Pharmaceuticals’ Promising Phase II Study on Ifetroban for IPF - TipRanks
Will Cumberland Pharmaceuticals Inc. stock rally after Fed decisionsWeekly Loss Report & Verified Trade Idea Suggestions - Fundação Cultural do Pará
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.42%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):